A new MAGE gene with ubiquitous expression does not code for known MAGE antigens recognized by T cells

Cancer Research

Volumn 59, Issue 16, 1999, Pages 4100-4103

  Lucas, Sophie ^a,b   Brasseur, Francis ^a   Boon, Thierry ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN RECOGNITION; ARTICLE; EXON; GENE EXPRESSION; GENE LOCATION; HLA SYSTEM; INTRON; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; T LYMPHOCYTE;

ADULT; AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; CHROMOSOME MAPPING; CYTOTOXICITY, IMMUNOLOGIC; GENE EXPRESSION; HUMANS; MALE; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; SEQUENCE ALIGNMENT; T-LYMPHOCYTES; X CHROMOSOME;

EID: 0033566760     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. van der Bruggen, P., Traversai, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., and Boon, T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Washington DC), 254: 1643-1647, 1991.
2. De Plaen, E., Arden, K., Traversari C., Gaforio, J. J., Szikora, J-P., De Smet, C., Brasseur, F., van der Bruggen, P., Lethé, B., Lurquin, C., Brasseur, R., Chomez, P., De Backer, O., Cavenee, W., and Boon, T. Structure, chromosomal localization and expression of twelve genes of the MAGE family. Immunogenetics, 40: 360-369, 1994.
3. Rogner, U. C., Wilke, K., Steck, E., Korn, B., and Poustka, A. The melanoma antigen gene (MAGE) family is clustered in the chromosomal band Xq28. Genomics, 29: 725-731, 1995.
4. Muscatelli, F., Walker, A. P., De Plaen, E., Stafford, A. N., and Monaco, A. P. Isolation and characterization of a new MAGE gene family in the Xp21.3 region. Proc. Natl. Acad. Sci. USA, 92: 4987-4991, 1995.
5. Dabovic, B., Zanaria, E., Bardoni, B., Lisa, A., Bordignon, C., Russo, V., Matessi, C., Traversari C., and Camerino, G. A family of rapidly evolving genes from the sex reversal critical region in Xp21. Mamm. Genome, 6: 571-580, 1995.
6. Lurquin, C., De Smet, C., Brasseur, F., Muscatelli, F., Martelange, V., De Plaen, E., Brasseur, R., Monaco, A. P., and Boon, T. Two members of the human MAGE-B gene family located in Xp21.3 are expressed in tumors of various histological origins. Genomics, 46: 397-408, 1997.
7. Lucas, S., De Smet, C., Arden, K. C., Viars, C. S., Lethé, B., Lurquin, C., and Boon, T. Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res., 58: 743-752, 1998.
8. De Smet, C., De Backer, O., Faraoni, I., Lurquin, C., Brasseur, F., and Boon, T. The activation of human gene MAGE-I in tumor cells is correlated with genome-wide demethylation. Proc. Natl. Acad. Sci. USA, 93: 7149-7153, 1996.
9. Weynants, P., Lethé, B., Brasseur, F., Marchand, M., and Boon, T. Expression of MAGE genes by non-small-cell lung carcinomas. Int. J. Cancer, 56: 826-829, 1994.
10. Jay, P., Rougeulle, C., Massacrier, A., Moncla, A., Mattei, M-G., Malzac, P., Roëckel, N., Taviaux, S., Bergé Lefranc, J-L., Cau, P., Berta, P., Lalande, M., and Muscatelli, F. The human necdin gene, NDN, is maternally imprinted and located in the Prader-Willi syndrome chromosomal region. Nat. Genet., 17: 357-361, 1997.
11. Uetsuki, T., Takagi, K., Sugiura, H., and Yoshikawa, K. Structure and expression of the mouse necdin gene. J. Biol. Chem., 271: 918-924, 1996.
12. Van den Eynde, B. and van der Bruggen, P. T cell-defined tumor antigens. Curr. Opin. Immunol., 9: 684-693, 1997.
13. Kawashima, I., Hudson, S., Tsai, V., Southwood, S., Takesako, K., Appella, E., Sette, A., and Celis, E. The multi-epitope approach for immunotherapy for cancer: identification of several CTL epitopes from various tumor-associated antigens expressed on solid epithelial tumors. Hum. Immunol., 59: 1-14, 1998.
14. Tanaka, F., Fujie, T., Tahara, K., Mori, M., Takesako, K., Sette, A., Celis, E., and Akiyoshi, T. Induction of antitumor cytotoxic T lymphocytes with a MAGE-3-encoded synthetic peptide presented by human leukocytes antigen-A24. Cancer Res., 57: 4465-4468, 1997.
15. Chaux, P., Vantomme, V., Stroobant, V., Thielemans, K., Corthals, J., Luiten, R., Eggermont, A. M., Boon, T., and van der Bruggen, P. Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes. J. Exp. Med., 189: 767-778, 1999.
16. Fleischhauer, K., Gattinoni, L., Dalerba, P., Lauvau, G., Zanaria, E., Dabovic, B., van Endert, P., Bordignon, C., and Traversari, C. The DAM gene family encodes a new group of tumor-specific antigens recognized by human leukocyte antigen A2-restricted cytotoxic T lymphocytes. Cancer Res., 58: 2969-2972, 1998.
17. Fujie, T., Tahara, K., Tanaka, F., Mori, M., Takesako, K., and Akiyoshi, T. A AMGE-1-encoded HLA-A24-binding synthetic peptide induces specific anti-tumor cytotoxic T lymphocytes. Int. J. Cancer, 80: 169-172, 1999.
18. Huang, L-Q., Brasseur, F., Serrano, A., De Plaen, E., van der Bruggen, P., Boon, T., and Van Pel, A. Cytolytic T lymphocytes recognize an antigen encoded by MAGE-A10 on a human melanoma. J. Immunol., 162: 6849-6854, 1999.
19. Zorn, E., and Hercend, T. A MAGE-6-encoded peptide is recognized by expanded lymphocytes infiltrating a spontaneously regressing human primary melanoma lesion. Eur. J. Immunol., 29: 602-607, 1999.
20. Manici, S., Sturniolo, T., Imro, M. A., Hammer, J., Sinigaglia, F., Noppen, C., Spagnoli, G., Mazzi, B., Bellone, M., Dellabona, P., and Protti, M. P. Melanoma cells present a MAGE-3 epitope to CD4(+) cytotoxic T cells in association with histocompatibility leukocyte antigen DR11. J. Exp. Med., 189: 871-876, 1999.
21. De Backer, O., Verheyden, A-M., Martin, B., Godelaine, D., De Plaen, E., Brasseur, R., Avner, P., and Boon, T. Structure, chromosomal location, and expression pattern of three mouse genes homologous to the human MAGE genes. Genomics, 28: 74-83, 1995.